- Monte Rosa Therapeutics (NASDAQ:GLUE) said Thursday it has priced an underwritten public offering of stock and warrants to raise up to $100 million.
- The company said it would offer 10,638,476 shares of its common stock at $4.70 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 10,638,524 shares of common stock at $4.6999 per pre-funded warrant.
- The financing was led by Dimension and a life-sciences focused institutional investor, with participation from other new and existing investors.
- TD Cowen and Wedbush PacGrow are acting as joint book-running managers for the offering.
- Press Release.
Monte Rosa Therapeutics prices $100M stock and warrants offering
